Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Quotti Tubi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Oncology|November 1, 2021
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell LymphomaSabrina Manni, Anna Fregnani, Laura Quotti Tubi, et al.
Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.
Oncotarget|January 19, 2017
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathwaysSabrina Manni, Marilena Carrino, Martina Manzoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein responseSabrina Manni, Alessandra Brancalion, Laura Quotti Tubi, et al.
Frontiers in Immunology|May 29, 2024
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapyEdoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.
Hemasphere|November 29, 2023
CK2β Regulates Hematopoietic Stem Cell Biology and ErythropoiesisLaura Quotti Tubi, Sara Canovas Nunes, Elisa Mandato, et al.
Frontiers in Immunology|January 30, 2023
CK2β-regulated signaling controls B cell differentiation and functionLaura Quotti Tubi, Elisa Mandato, Sara Canovas Nunes, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Oncology|November 1, 2021
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell LymphomaSabrina Manni, Anna Fregnani, Laura Quotti Tubi, et al.
Plos One|October 3, 2013
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cellsSabrina Manni, Alessandra Brancalion, Elisa Mandato, et al.
Oncotarget|January 19, 2017
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathwaysSabrina Manni, Marilena Carrino, Martina Manzoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein responseSabrina Manni, Alessandra Brancalion, Laura Quotti Tubi, et al.
Frontiers in Immunology|May 29, 2024
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapyEdoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.
Hemasphere|November 29, 2023
CK2β Regulates Hematopoietic Stem Cell Biology and ErythropoiesisLaura Quotti Tubi, Sara Canovas Nunes, Elisa Mandato, et al.
Frontiers in Immunology|January 30, 2023
CK2β-regulated signaling controls B cell differentiation and functionLaura Quotti Tubi, Elisa Mandato, Sara Canovas Nunes, et al.
Pageof 2